Responses
E-Posters
E-Poster Viewing
EPV036/#142 European network for gynaecological oncological trial (ENGOT)-CX11/gynecologic oncology group (GOG) 3047/keynote-A18: phase 3 trial of pembrolizumab plus chemoradiotherapy in high-risk locally advanced cervical cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.